Values as of: 2024-04-26
COMMON STOCK | Medical Devices | OTC Pink
Last Closing
USD 270.05Change
0.00 (0.00)%Market Cap
USD 8.64BVolume
N/AAnalyst Target
N/AVerdict
Verdict
Sonova Holding AG along with its subsidiaries is engaged in the design, development, manufacture, distribution and service of technologically advanced hearing systems for adults and children with hearing impairment.
Company Website : http://www.sonova.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| SEMHF | Siemens Healthineers AG |
N/A |
USD 63.37B |
| SMMNY | Siemens Healthineers AG ADR |
-0.31 (-1.09%) |
USD 63.37B |
| RYLPF | Koninklijke Philips N.V |
-0.68 (-2.52%) |
USD 18.28B |
| SONVY | Sonova Holding AG |
+0.82 (+1.41%) |
USD 16.80B |
| CHEOF | Cochlear Limited |
+8.00 (+3.85%) |
USD 13.75B |
| CHEOY | CochLear Ltd ADR |
+0.77 (+0.71%) |
USD 13.71B |
| WILLF | Demant A/S |
N/A |
USD 11.14B |
| SNNUF | Smith & Nephew plc |
-0.22 (-1.74%) |
USD 10.71B |
| WILYY | Demant A/S ADR |
-0.95 (-4.04%) |
USD 10.43B |
| GNGBF | Getinge AB |
N/A |
USD 5.73B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| EMID:LSE | iShares MSCI Europe Mid C.. | 0.00 % | 0.00 % |
+0.09 (+1.52%) |
USD 6.95M |
| EUMD:LSE | iShares MSCI Europe Mid C.. | 0.00 % | 0.00 % |
+0.11 (+1.52%) |
USD 0.07B |
| Market Performance vs. Industry/Classification (Medical Devices) | Market Performance vs. Exchange (OTC Pink) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -16.18% | 45% | F | 29% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -16.18% | 45% | F | 28% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -15.25% | 60% | D- | 48% | F | ||
| Dividend Return | 1.61% | 42% | F | 19% | F | ||
| Total Return | -13.64% | 60% | D- | 47% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 36.30% | 77% | C+ | 78% | C+ | ||
| Dividend Return | 8.15% | 73% | C | 27% | F | ||
| Total Return | 44.45% | 77% | C+ | 77% | C+ | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 11.28% | 60% | D- | 58% | F | ||
| Dividend Return | 12.38% | 60% | D- | 55% | F | ||
| Total Return | 1.10% | 68% | D+ | 26% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 33.92% | 80% | B- | 66% | D+ | ||
| Risk Adjusted Return | 36.51% | 82% | B | 74% | C | ||
| Market Capitalization | 8.64B | 97% | N/A | 93% | A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median revenue growth in the previous 5 years compared to its sector
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
